Andrea Corcoran J.'s Insider Trades & SAST Disclosures
Andrea Corcoran J.'s most recent trade in Atea Pharmaceuticals Inc was a trade of 200,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Andrea Corcoran J..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 44,367 | 44,366 | - | - | Restricted Stock Units | |
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 44,367 | 722,909 | - | - | Common Stock | |
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.06 per share. | 31 Jan 2025 | 16,102 | 717,307 | - | 3.1 | 49,272 | Common Stock |
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 10,500 | 10,500 | - | - | Restricted Stock Units | |
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 10,500 | 733,409 | - | - | Common Stock | |
| Atea Pharmaceuticals Inc | J. Andrea Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 44,367 | 686,051 | - | - | Common Stock | |
| Atea Pharmaceuticals Inc | J. Corcoran Andrea | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 44,367 | 88,733 | - | - | Restricted Stock Units | |
| Atea Pharmaceuticals Inc | Andrea Corcoran J. | See Remarks | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 31 Jan 2024 | 15,843 | 670,208 | - | 3.8 | 60,915 | Common Stock |
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 186,300 | 186,300 | - | - | Stock Option (Right to Buy) | |
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 133,100 | 133,100 | - | - | Restricted Stock Units | |
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 181,000 | 181,000 | - | - | Stock Option (Right to Buy) | |
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 148,850 | 148,850 | - | - | Stock Option (Right to Buy) | |
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | 03 Nov 2020 | 133,004 | 633,004 | - | - | Common Stock | ||
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | 03 Nov 2020 | 100,000 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Atea Pharmaceuticals Inc | Andrea J. Corcoran | See Remarks | 03 Nov 2020 | 33,004 | 0 | - | - | Series B Convertible Preferred Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges